Loading stock data…
$11.28-0.10 (-0.88%)
Cellebrite DI Ltd.
Cellebrite DI Ltd. in the Technology sector is trading at $11.28 with a market capitalization of $2.8B. Wall Street consensus targets $15.36 (7 analysts), implying a +36.1% move over the next 12 months. The stock is currently near its 52-week low of $9.58, remaining 18.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $131.14M↑ | $128.30M↓ | $128.82M↑ | $126.03M↑ | $113.28M |
| Gross Profit | $105.93M | $105.88M↓ | $109.13M↑ | $105.72M↑ | $95.60M |
| Operating Income | $6.95M↓ | $9.12M↓ | $20.80M↑ | $18.99M↑ | $14.42M |
| Net Income | $6.37M↓ | $10.94M↓ | $21.26M↑ | $20.19M↑ | $19.48M |
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, ext...